ATARA BIOTHERAPEUTICS, INC.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2016 | $-60.0M | $-63.0M | $3.0M | $16.8M |
| FY2017 | $-87.5M | $-107.7M | $20.2M | $23.1M |
| FY2018 | $-179.8M | $-215.7M | $35.9M | $33.8M |
| FY2019 | $-235.6M | $-241.4M | $5.7M | $51.7M |
| FY2020 | $-180.8M | $-185.3M | $4.5M | $51.4M |
| FY2021 | $-220.5M | $-231.1M | $10.6M | $53.9M |
| FY2022 | $-270.4M | $-274.6M | $4.2M | $53.8M |
| FY2023 | $-193.0M | $-194.2M | $1.2M | $45.4M |
| FY2024 | $-68.7M | $-69.0M | $246.0K | $27.0M |
| FY2025 | $-50.9M | $-50.9M | $0 | $9.8M |